Biocatalysis & Biocatalyst Sector: Growth Drivers and Challenges;
Growth drivers
- Surging Adoption in Processed Foods- There has been an increasing substitution of natural bio enzymes for chemical-based additives in processed food. In addition, several research has indicated that the bio preservative added to processed food is better than harmful chemical for digestive health. As per the analysis, more than 60 percent of adults eat ultra-processed foods across the globe.
- Demand for Low-Cost Biological Procedures: - On the back of replacing chemical catalysts and providing low-cost processes in biological activity industries, bio-catalysis, and biocatalysts are expected to drive biocatalysis & biocatalysts market demand over the forecast period. Demand in the market is primarily driven by the lower cost of synthesis and widespread use.
- Increase In Demand for the Pharmaceutical Industry- Increased demand for the medicines used to manufacture pharmaceuticals is boosting the market growth by developing pharmacies globally. As a result of the higher demand for drugs used in the manufacture of pharmaceutical products pharmaceutical industry has performed well over the past years. Changes in clinical practice and increasing concern over chronic disease and aging are driving up the consumption of pharmaceutical products. India's pharmaceuticals biocatalysis & biocatalysts market growth rates, are 40% of generic demand in the US and 25% of all medicines in the UK. revenues in the pharmaceutical industry are growing year on year.
Challenges
- Technical Barriers Affecting Industry; -Bio catalysis is an enzyme that speeds up the chemical process by using biomolecules. A moderate reaction and very selective conditions are present. Biocatalysts are therefore a significant factor in the chemical industry, and their importance for industrial uses is increasing. However, the exact structure of biocatalyst proteins is difficult to find. This process takes time to complete, requiring a larger number of catalysts in order for the reactions to take place.
- Less adequate regulations
- High Cost for Research and Development
Biocatalysis & Biocatalysts Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
4.9% |
|
Base Year Market Size (2024) |
USD 669.04 million |
|
Forecast Year Market Size (2037) |
USD 1.24 billion |
|
Regional Scope |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of biocatalysis & biocatalysts is evaluated at USD 722.52 million.
The biocatalysis & biocatalysts market size was valued at USD 669.04 million in 2024 and is expected to reach USD 1.24 billion by 2037, expanding at around 4.9% CAGR during the forecast period i.e., between 2025-2037. Increased demand for the medicines used to manufacture pharmaceuticals will drive the market growth.
North America industry is anticipated to hold largest revenue share of 34% by 2037, as use of biocatalysts to produce biochemicals, biofuels, and other biomaterial have been playing a significant role in waste reduction which is making them very effective for use in the chemical sector in the region.
The major players in the market are DuPont de Nemours, Inc., BASF SE, Novozymes A/S, Lonza Group Ltd., Royal DSM Lockheed Martin, Codexis, Inc., AB Enzymes, Sapporo Enzyme Co., Ltd., Dyadic International, Inc., Soufflet Group
